Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sebastian,Stefanovic

第一单位： Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

作者： Sebastian,Stefanovic ^[1] ; Iris,Detrez ^[2] ; Griet,Compernolle ^[2] ; Els,Brouwers ^[2] ; Nejc,Sever ^[1] ; Borut,Stabuc ^[3] ; Natasa,Smrekar ^[1] ; Tina,Kurent ^[1] ; Gregor,Novak ^[1] ; Matic,Kozelj ^[1] ; Marc,Ferrante ^[4] ; Ann,Gils ^[2] ; David,Drobne ^[3]

作者单位： Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia. ^[1] Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium. ^[2] Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.;Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. ^[3] Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. ^[4]

主题词抗体, 单克隆(Antibodies, Monoclonal);结肠炎, 溃疡性(Colitis, Ulcerative);内窥镜检查(Endoscopy);人类(Humans);缓解诱导(Remission Induction);治疗结果(Treatment Outcome)

DOI 10.1097/MEG.0000000000001843

PMID 32804854

发布时间 2023-09-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交